Sanofi (SNY) Cash from Investing Activities (2009 - 2026)

Sanofi has reported Cash from Investing Activities for 7 years, with the latest figure at -$424.3 million in Q2 2026.

• Quarterly Cash from Investing Activities fell 103.94% year-over-year to -$424.3 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$6.3 billion (down 422.44% YoY) and the FY2025 annual result came in at -$2.8 billion, up 39.52% from the prior year.
• Cash from Investing Activities grew to -$424.3 million in Q2 2026 per SNY's latest filing, from -$2.7 billion in the prior quarter.
• Over five years, Cash from Investing Activities peaked at $10.8 billion in Q2 2025 and troughed at -$4.7 billion in Q4 2024.
• A 3-year average of -$528.5 million and a median of -$816.3 million in 2025 frame the typical range for Cash from Investing Activities.
• The sharpest annual moves came in 2025 and 2026: Cash from Investing Activities soared 428.48% in 2025, then sank 226.73% in 2026.
• Over 3 years, Cash from Investing Activities stood at -$4.7 billion in 2024, then jumped by 39.52% to -$2.8 billion in 2025, then jumped by 85.11% to -$424.3 million in 2026.
• According to Business Quant data, Cash from Investing Activities over the past three periods registered -$424.3 million, -$2.7 billion, and -$2.8 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.